Invention Grant
US08592596B2 Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
有权
4- [2-（2-氟苯氧基甲基）苯基]哌啶化合物的结晶形式
![Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound](/docs/US/2013-11-26/US08592596B2/abs.jpg.600x600.jpg)
- Patent Title: Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
- Patent Title (中): 4- [2-（2-氟苯氧基甲基）苯基]哌啶化合物的结晶形式
-
Application No.: US13632588Application Date: 2012-10-01
-
Publication No.: US08592596B2Publication Date: 2013-11-26
- Inventor: Lori Jean Patterson , Robert S. Chao , Miroslav Rapta
- Applicant: Theravance, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Theravance, Inc.
- Current Assignee: Theravance, Inc.
- Current Assignee Address: US CA South San Francisco
- Agent Jeffrey A. Hagenah; Shelley Eberle
- Main IPC: C07D211/22
- IPC: C07D211/22
![Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound](/abs-image/US/2013/11/26/US08592596B2/abs.jpg.150x150.jpg)
Abstract:
The invention provides a crystalline hydrochloride salt of 4-[2-(2,4,6-trifluorophenoxymethyl)phenyl]piperidine. This invention also provides pharmaceutical compositions comprising the crystalline salt, processes and intermediates for preparing the crystalline salt, and methods of using the crystalline salt to treat diseases.
Public/Granted literature
- US20130030185A1 CRYSTALLINE FORM OF A 4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUND Public/Granted day:2013-01-31
Information query
